Connect Biopharma Holdings Limited
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & Equivalents | $38.3M | $78.2M | $105.7M | $78.9M | $267.7M |
| Accounts Receivable | $13.0K | $789.0K | $0 | — | — |
| Inventory | — | — | — | — | — |
| Total Current Assets | $50.9M | $97.0M | $122.6M | $155.8M | $275.1M |
| Property, Plant & Equipment | $3.8M | $4.0M | $4.3M | — | — |
| Goodwill | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | $45.0K | $53.0K | $62.0K | — | — |
| Total Assets | $56.1M | $101.3M | $127.4M | $174.0M | $291.1M |
| Liabilities | |||||
| Accounts Payable | $2.0M | $342.0K | $2.2M | $11.9M | $12.7M |
| Total Current Liabilities | $13.6M | $8.5M | $25.3M | $15.6M | $18.0M |
| Long-Term Debt | — | — | — | — | — |
| Total Liabilities | $14.1M | $9.1M | $25.9M | $15.6M | $18.8M |
| Stockholders' Equity | |||||
| Retained Earnings | $-400.8M | $-345.4M | $-329.7M | $-479.8M | $-361.8M |
| Total Stockholders' Equity | $42.0M | $92.2M | $101.5M | $158.4M | $272.3M |